| Obesity |
1 |
1 |
| Face |
0 |
0.98 |
| Weight Management |
0 |
0.84 |
| Weight Loss |
0 |
0.59 |
| Thyroid Disease |
0 |
0.29 |
| Biliary Disease |
0 |
0.22 |
| Renal Failure |
0 |
0.22 |
| Patient Safety |
0 |
0.21 |
| Type 2 Diabetes Mellitus |
0 |
0.21 |
| Head and Neck Cancer |
0 |
0.2 |
| Wasting |
0 |
0.2 |
| Revenue and Practice Management |
0 |
0.19 |
| Thyroid Cancer |
0 |
0.16 |
| Adverse Effects |
0 |
0.15 |
| Pain Management |
0 |
0.12 |
| Medullary Thyroid Cancer |
0 |
0.11 |
| Brain |
0 |
0.1 |
| Brain Tumor |
0 |
0.1 |
| Chronic Kidney Disease |
0 |
0.1 |
| Prescription Drugs |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Social Media |
0 |
0.1 |
| Thyroid |
0 |
0.1 |
| Abdominal Pain |
0 |
0.09 |
| Abdominal Infection |
0 |
0.07 |
| Acute Kidney Injury |
0 |
0.07 |
| Anaphylaxis |
0 |
0.07 |
| Cancer Risk |
0 |
0.07 |
| Cardiovascular Risk Management |
0 |
0.07 |
| Constipation |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Health Insurance |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Pancreatitis |
0 |
0.07 |
| Wound Management |
0 |
0.07 |
| Abdomen |
0 |
0.05 |
| Animal Research |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Gallstone |
0 |
0.05 |
| Hypercholesterolemia |
0 |
0.05 |
| Incretin Hormone |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Nausea |
0 |
0.05 |
| New York |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Quality of Life |
0 |
0.05 |
| Radiofrequency (RF) Energy |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Ultrasonography |
0 |
0.05 |